GondolaBio
- Biotech or pharma, therapeutic R&D
GondolaBio is a private biotech company focused on developing therapeutics to treat genetic diseases at the source. We spun out of BridgeBio in 2024. Our team includes Frank McCormick, Phil Reilly, Charles Homcy, Richard Scheller, and Neil Kumar. Many of our programs are based on licensed technology from academic research institutions, including UCSF, Stanford University, St. Jude, and Boston Children's Hospital.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}